HIC1 is a zinc finger transcriptional repressor that recognizes specific DNA consensus sequences and functions as a tumor suppressor 123. The protein mediates transcriptional repression through interactions with corepressors including CTBP1/CTBP2 and MTA1, the latter suggesting association with the NuRD chr17-remodeling complex 14. HIC1 regulates multiple biological pathways: it suppresses SIRT1 expression, thereby modulating p53-dependent apoptotic responses to DNA damage 5, cooperates with MTA1 to repress cell-cycle genes CCND1 and CDKN1C in quiescent cells 4, and negatively regulates Wnt signaling by preventing TCF7L2-β-catenin association with target promoters 6. In wound healing, HIC1 marks quiescence-associated extrafollicular fibroblast progenitors that generate reparative cells, with regenerative capacity modifiable through RUNX1 and retinoic acid signaling 7. HIC1 plays emerging roles in ferroptotic cell death regulation and immune homeostasis 89. Clinically, HIC1 expression correlates with cancer prognosis, immunotherapy response to PD-1/PD-L1 inhibitors, and drug sensitivity across multiple cancer types 10. HIC1 genetic variants associate with laryngeal cancer susceptibility 11, while HIC1 represses HIV-1 transcription through CTIP2 and HMGA1 interactions in latently infected cells 12.